FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 6114170 · Received November 18, 2016

Report

Report Number
2024168-2016-08114
Event Type
Injury
Date Received
November 18, 2016
Date of Event
September 25, 2014
Report Date
November 18, 2016
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
UDI-DI
08717648063107
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD IDENTIFIED NO MANUFACTURING NONCONFORMITIES ISSUED TO THE REPORTED LOT THAT WOULD HAVE CONTRIBUTED TO THIS EVENT. BASED ON THE CASE INFORMATION AND RELATED RECORD REVIEW, A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THE REPORTED PATIENT EFFECT OF ANGINA IS LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY STENTING PROCEDURES. BASED ON THE INFORMATION REVIEWED, THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO THE DESIGN, MANUFACTURE, OR LABELING OF THE DEVICE.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2011, THE PATIENT UNDERWENT A CORONARY PROCEDURE WITH IMPLANTATION OF A 4.0 X 15 MM XIENCE V STENT IN THE LEFT MAIN CORONARY ARTERY. ON (B)(6) 2014, THE PATIENT EXPERIENCED ANGINA AND WAS RE-HOSPITALIZED ON (B)(6) 2014. ELECTROCARDIOGRAM AND TROPONIN I LEVELS WERE OBTAINED, WITH NORMAL RESULTS. TRADITIONAL (B)(6) MEDICATION WAS PROVIDED AND THE ANGINA RESOLVED ON (B)(6) 2014. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
763647 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 0052641 08717648063107

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization| R